IFNG and COVID-19: This may be attributable to the greater spike-specific IFN-γ T-cell responses observed in CR vaccinees at this timepoint—recent literature suggests significant associations between heightened type I and type II interferon signaling and delayed anti-RBD antibody kinetics in COVID-19 patients (74).